| Plag1 and Plagl2 are novel leukemia oncogenes that act by expanding hematopoietic progenitors expressing CbF beta-SMMHC. | leukemia, |
| Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. | leukemia, |
| miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. | leukemia, |
| Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs. | leukemia, |
| Overexpression of the oncogene PLAG1 is associated with the pathogenesis of chronic lymphocytic leukemia. | leukemia, |
| PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. | None |
| Microarray screening for target genes of the proto-oncogene PLAG1. | None |
| Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation. | None |
| Targeted disruption of the murine Plag1 proto-oncogene causes growth retardation and reduced fertility. | None |
| Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression. | None |
| Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice. | None |
| PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). | None |
| The importance and versatility of the PLAG1 oncogene in tumourigenesis is discussed. | None |
| aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice. | None |
| MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice. | None |
| results establish the oncogenic potential of PLAG1 in mammary glands of mice and point towards contributing roles of Igf and Wnt signaling | None |